Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**2s,4r-4-Methylglutamate** is a synthetic amino acid derivative and a structural analog of glutamic acid. It is characterized by its specific stereochemistry at the 2 and 4 positions. This compound acts as a highly selective and potent agonist for kainate-type ionotropic glutamate receptors in the central nervous system. At higher concentrations, it also selectively inhibits the excitatory amino acid transporter EAAT2. Due to these properties, it is primarily used as an experimental tool in neuroscience research to study excitatory neurotransmission and receptor pharmacology[5][3][7]. There are no approved therapeutic indications or clinical uses for this compound.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2s,4r-4-methylglutamate.